UPDATED Jun 09, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NVDA | US$120.89 | 10.3% | 211.8% | US$3.0t | US$1,468.88 | PE7x | E22.6% | 0.1% | Semiconductors | ||
ARES | US$132.93 | -3.8% | 43.1% | US$41.2b | US$153.58 | PE60.2x | E42.2% | 2.8% | Diversified Financials | ||
NU | US$11.89 | 1.2% | 56.0% | US$56.8b | US$12.46 | PB8.4x | E37.7% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
PDD | US$143.90 | -2.1% | 89.1% | US$199.8b | US$205.37 | PE18.1x | E23.1% | n/a | Retail | ||
CG | US$40.68 | -6.3% | 34.2% | US$14.6b | US$48.47 | PS6.6x | E23.6% | 3.4% | Diversified Financials | ||
SMCI | US$769.11 | -0.2% | 197.4% | US$45.0b | US$1,032.47 | PE42.9x | E40.2% | n/a | Tech | ||
CELH | US$73.20 | -2.4% | 52.4% | US$17.1b | US$90.35 | PE79.2x | E21.7% | n/a | Food, Beverage & Tobacco | ||
OWL | US$16.69 | -6.1% | 46.8% | US$23.8b | US$21.46 | PE122.2x | E90.8% | 4.3% | Diversified Financials | ||
CHK | US$88.29 | -3.0% | 11.8% | US$11.6b | US$105.22 | PE11x | E36.2% | 2.8% | Energy | ||
RYAN | US$53.85 | -5.1% | 26.2% | US$14.0b | US$58.00 | PE100.8x | E76.5% | 0.8% | Insurance | ||
TER | US$140.90 | -0.09% | 28.7% | US$22.0b | US$128.91 | PE51.2x | E23.8% | 0.3% | Semiconductors | ||
ONON | US$42.35 | 2.7% | 38.5% | US$13.5b | US$40.84 | PE95.6x | E25.9% | n/a | Consumer Durables | ||
ZS | US$180.99 | 7.1% | 16.0% | US$27.4b | US$229.94 | PS13.5x | E51.5% | n/a | Software | ||
SPOT | US$308.21 | -1.7% | 104.7% | US$61.1b | US$343.54 | PS4.1x | E40.6% | n/a | Media | ||
SRPT | US$123.32 | -0.7% | -5.2% | US$11.7b | US$166.99 | PE689.9x | E37.5% | n/a | Pharmaceuticals & Biotech | ||
PTC | US$174.48 | 0.2% | 24.1% | US$20.9b | US$203.05 | PE72.6x | E22.8% | n/a | Software | ||
ALNY | US$152.78 | 1.5% | -20.9% | US$19.3b | US$220.15 | PS9.6x | E64.1% | n/a | Pharmaceuticals & Biotech | ||
NTNX | US$52.37 | -1.2% | 76.3% | US$12.8b | US$73.54 | PS6.1x | E82.6% | n/a | Software | ||
VRT | US$87.68 | -8.8% | 315.3% | US$32.8b | US$101.72 | PE81.2x | E30.3% | 0.1% | Capital Goods | ||
CRWD | US$349.12 | 13.1% | 131.0% | US$85.0b | US$399.46 | PE645.3x | E34.9% | n/a | Software | ||
HUBS | US$596.65 | -0.08% | 14.5% | US$30.4b | US$673.75 | PS13.3x | E52.4% | n/a | Software | ||
MPWR | US$751.64 | 2.7% | 42.8% | US$36.6b | US$775.53 | PE89.2x | E20.4% | 0.7% | Semiconductors | ||
FTI | US$24.27 | -0.9% | 66.6% | US$10.5b | US$28.49 | PE58.2x | E28.8% | 0.8% | Energy |